Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma

Clinical trial NCT01476787 · COMPLETED

Trial details

NCT number: NCT01476787
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Follicular Lymphoma

Start date: 2011-12-29
Primary completion: 2024-04-30
Enrollment: 1030

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.